On current market cap ($210M) and at $50M per quarter revenue,...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 8419 Last

Share
Profile

Follow
Richard OZ

116 Posts.

08/06/17

16:09

Post #: 25178211
Share

Originally posted by MyBentley ↑

When someone is selling someone is buying.
This is a good thing.
RAP has a positive flow of everything.

Great clinical results right from the start.
Pediatric clinical trials are nothing but incredible.

Our Resapp diagnosis in Australian trials of over 1000 children has been put up to the standards of a child with a cough having presented at the hospital has a history taken, a nurse and then a doctor have a chat with the parent about symptoms, the doctor listens, blood pressure is done, temperature is taken, oxygen saturation is measured, bloods are taken by needles, the doctor listens to the lungs and then orders Xrays, a swab is placed in sick child s mouth for pathology cultures. The doctor chats with other doctors medical team members. All the information is then looked over by a pediatrician and a diagnosis is given.
And with all that expert best of today information costing $$$$$$ thousands of dollars and medical resources for each child is only 75-85% accurate.

A Resapp diagnosis for $10 is totally quiet and non invasive with no trauma to the child or parent. The child with parents taken to quiet room for a few minutes and the sound of the cough is recorded and then resapp makes an instant diagnosis.
Already accurate on over 1000 Australian children (Multicultural population) with a greater than 95% accuracy.

RAP has brilliant associations with three of the biggest and best hospitals in the USA and the Harvard Medical School .
Massachusetts General Hospital has strong connections with US telemedicine and especially Amwell.
RAP has the interest and support from the founder of Apple computers.

This current FDA trial has been carried out in optimum conditions for cough sound audio collection.

Post FDA approval I see three of the biggest and best hospitals in the US, Bill Gates, and Apple creating and spreading a media storm of positive Resapp information around the planet.

I see conservatively at least 5 million uses at $10.00 per use of resapp diagnosing children in its first financial quarter of world use in telehealth visits and hospitals.

Are we there yet?
We are here and all is very well.

Luv RAP
MB

Expand

On current market cap ($210M) and at $50M per quarter revenue, so $200M pa exclusive of costs, that's so close to my dream P/E ratio of 1.0

RAP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

There are more pages in this discussion • 7 more messages in this thread...

First 8419 Last

Add RAP (ASX) to my watchlist

On current market cap ($210M) and at $50M per quarter revenue,...

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Banshee's historic trenches prove rich in antimony and gold for GDM

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News